首页> 外文OA文献 >Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor 14Ccopanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers

【2h】

Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor 14Ccopanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers

机译：静脉内泛级磷脂酰肌醇的药代动力学3-激酶（PI3K）抑制剂14C Copanlisib（Bay 80-6946）在健康男性志愿者中的大规模平衡研究中

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Michael Gerisch; Thomas Schwarz; Dieter Lang; Gabriele Rohde; Stefanie Reif; Isabelle Genvresse; Susanne Reschke; Dorina van der Mey; Camille Granvil;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor [C-14]copanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers [J] . Gerisch Michael, Schwarz Thomas, Lang Dieter, Cancer chemotherapy and pharmacology. . 2017,第3期

机译：静脉内泛级磷脂酰肌醇的药代动力学3-激酶（PI3K）抑制剂[C-14] CopAnlisib（Bay 80-6946）在健康男性志愿者中的质量平衡研究中
2. First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas [J] . Patnaik A., Appleman L. J., Tolcher A. W., Annals of oncology: official journal of the European Society for Medical Oncology . 2016,第10期

机译：潘诺昔布（BAY 80-6946）的人类首次I期研究（静脉注射泛I类磷脂酰肌醇3-激酶抑制剂）用于晚期实体瘤和非霍奇金淋巴瘤患者
3. First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas [J] . Patnaik A., Appleman L. J., Tolcher A. W., Annals of oncology: official journal of the European Society for Medical Oncology . 2016,第10期

机译：第一阶段I研究Copanlisib（Bay 80-6946），一种静脉内泛级磷脂酰肌醇3-激酶抑制剂，在先进的实体瘤和非霍奇金淋巴瘤患者中
4. Pharmacokinetics of Gabapentin After Single and Repeated Dosing of Gabapentin Extended Release Tablets (G-ER) and Instant Release (IR) Tablets in Healthy Male andFemale Volunteers [C] . Toufigh Gordi, Eddie Hou, Bret Berner Controlled Release Society Annual Meeting and Exposition . 2007

机译：加巴喷丁缓释片（G-ER）和速释（IR）片在健康男性和女性志愿者中的单次和重复给药后，加巴喷丁的药代动力学
5. Clinical Pharmacokinetics of the Novel Combination of BEZ235, PI3K/mTOR Inhibitor, and Everolimus, mTOR Inhibitor: Phase I Clinical Studies and Non-Clinical Mechanistic Assessment [D] . Moorthy, Ganesh P. 2015

机译：BEZ235，PI3K / mTOR抑制剂和依维莫司，mTOR抑制剂的新型组合的临床药代动力学：I期临床研究和非临床机制评估
6. Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor 14Ccopanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers [O] . Michael Gerisch, Thomas Schwarz, Dieter Lang, -1

机译：在健康男性志愿者中进行质量平衡研究时静脉使用Pan I类磷脂酰肌醇3-激酶（PI3K）抑制剂14C copanlisib（BAY 80-6946）的药代动力学
7. 260P A phase I study of copanlisib, a pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor, in Chinese patients with relapsed indolent non-Hodgkin lymphoma (iNHL) [O] . Y. Song, W. Liu, Y. Niu, 2020

机译：260P I阶段研究Copanlisib，一种泛级I磷脂酰肌醇3-激酶（PI3K）抑制剂，在中国复发惰性非霍奇金淋巴瘤（INHL）中

Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor 14Ccopanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers

著录项

相似文献

相关主题

期刊订阅